Back to results
US 5,279,812 AGranted
Radiolabeled anticoagulant peptides
AssigneeMerrell Dow Pharmaceuticals Inc.
InventorsJohn L. Krstenansky, Simon J. T. Mao
Life of this patent
Estimating the term…
Abstract
This invention relates to the usage of anticoagulant peptide derivatives that are iodinated.
Claims16
A radio-labeled peptide derivative of the formula I (ID#26):
- (1)X-A.sub.1 -A.sub.2 -A.sub.3 -A.sub.4 -A.sub.5 -A.sub.6 -A.sub.7 -A.sub.8 -A.sub.9 -A.sub.10 -Y
- wherein;
- X is an amino terminal substituent selected from hydrogen, one or two alkyl groups of from 1 to 10 carbon atoms, one or two acyl groups of from 2 to 10 carbon atoms, carbobenzyloxy or t-butyloxy carbonyl;
- A.sub.1 is a sequence of 1-11 amino acids of hirudin (SEQ ID NO:1), or known naturally occurring amino acid sequence variation of hirudin (SEQ ID NO:2;
- SEQ ID NO:3), or a bond;
- A.sub.2 is one to five residues of [.sup.3 H]-Tyr, [.sup.125 I]-Tyr, [.sup.131 I]-Tyr;
- unless A.sub.9 contains a radio-labeled amino acid then A.sub.2 can additionally be I-Tyr, Tyr, or a bond;
- A.sub.3 is Glu, or Asp;
- A.sub.4 is Pro, or Glu;
- A.sub.5 is Ile;
- A.sub.6 is Tiq, Pro, Hyp, 3,4-dihydroPro, thiazolidine-4-carboxylate, Sar, NMePgl, Azt, or Pip;
- A.sub.7 is Glu, or Asp;
- A.sub.8 is Glu, Asdp, or Ala;
- A.sub.9 is a lipophilic amino acid selected from Tyr, I-Tyr, [.sup.125 I]-Tyr, [.sup.131 I]-Tyr, [.sup.3 H]-Tyr, Met, Trp, Phe, Leu, Nle, Ile, Val, Cha, His, Ala and Pro or is a dipeptide containing at least one of these amino acids and a amino acid found in hirudin (SEQ ID NO:1), or known naturally occurring amino acid sequence variation of hirudin (SEQ ID NO:2;
- SEQ ID NO:3);
- A.sub.10 is a sequence of 1-11 amino acids of hirudin (SEQ ID NO:1), or known naturally occurring amino acid sequence variation of hirudin (SEQ ID NO:2;
- SEQ ID NO:3), D-Glu, Glu, Gln, Asn, or a bond;
- Y is a carbonyl substituent (--CO--) of the terminal amino acid selected from OH, (C.sub.1 -C.sub.8) alkoxy, amino, or a mono or di (C.sub.1 -C.sub.4) alkyl substituted amino group;
- or the terminal substituent to the alpha carbon of the amino acid is an alcohol (CH.sub.2 OH);
- with the proviso that at least 3 amino acids of formula 1 correspond to amino acids present in hirudin (SEQ ID NO:1), or known naturally occurring amino acid sequence variation of hirudin (SEQ ID NO:
- 2;
- SEQ ID NO:3).
19 more elements
Dependencies are inferred from the claim text.